Fanconi Syndrome in Patients With Human Immunodeficiency Virus Treated With Tenofovir-Based Antiretroviral Therapy: A Systematic Literature Review
CONCLUSIONS: Occurrence of FS is low in patients with HIV treated with tenofovir-based regimens. Concomitant use of ritonavir may increase risk of FS. TAF may be a safer alternative than TDF in terms of nephrotoxicity.PMID:37932920 | DOI:10.1177/10600280231206703
Source: The Annals of Pharmacotherapy - Category: Drugs & Pharmacology Authors: Mrinmayee Joshi Brendan Clark Todd A Lee Source Type: research
More News: Clinical Trials | Conferences | Drugs & Pharmacology | Norvir | Study | Toxicology | Viread